Michail ignatiadis(@MIgnatiadis) 's Twitter Profileg
Michail ignatiadis

@MIgnatiadis

Director, Breast Medical Oncology Clinic & Program @JulesBordet, Chair Breast Cancer Group, @EORTC

ID:1318617576

calendar_today31-03-2013 15:55:31

1,1K Tweets

957 Followers

101 Following

OncoAlert(@OncoAlert) 's Twitter Profile Photo

New guidelines alert🚨
The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for offer personalized recommendations for screening, diagnosis, and treatment based on the latest data.

Emphasizing risk-adapted approaches and advanced imaging, these guidelines reflect

New guidelines alert🚨 The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for #ProstateCancer offer personalized recommendations for screening, diagnosis, and treatment based on the latest data. Emphasizing risk-adapted approaches and advanced imaging, these guidelines reflect
account_circle
Elisa Agostinetto(@ElisaAgostinett) 's Twitter Profile Photo

Free access to our editorial in Annals of Oncology at the link⬇️

The role of adjuvant pembro is unclear, as KEYNOTE-522 did not foresee a randomisation at surgery

It’s likely that adjuvant pembro has a lower impact compared to neoadj pembro

OncoAlert

authors.elsevier.com/c/1iw3x3I2OQif…

Free access to our editorial in @Annals_Oncology at the link⬇️ The role of adjuvant pembro is unclear, as KEYNOTE-522 did not foresee a randomisation at surgery It’s likely that adjuvant pembro has a lower impact compared to neoadj pembro @OncoAlert authors.elsevier.com/c/1iw3x3I2OQif…
account_circle
Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo

T-DXd is approved for the treatment of patients with ANY treatment-refractory HER2+ (IHC 3+) tumor, making of it the first agnostic ADC. Unlikely to be the last. Key priority: ensuring that HER2 testing is expanded across cancer types. Exciting times! fda.gov/drugs/resource…

T-DXd is approved for the treatment of patients with ANY treatment-refractory HER2+ (IHC 3+) tumor, making of it the first agnostic ADC. Unlikely to be the last. Key priority: ensuring that HER2 testing is expanded across cancer types. Exciting times! fda.gov/drugs/resource…
account_circle
Philippe Aftimos, MD (@aftimosp) 's Twitter Profile Photo

SOS !
L’océan est notre poumon mais il va mal.
Le protéger est une urgence vitale.
Rejoignez la coalition citoyenne pour l'océan et + de 100 ONG & personnalités pour agir avant qu'il ne soit trop tard et obtenir une protection réelle de l'océan dès 2024. oceancoalition.org #

account_circle
Paulo G Bergerot(@PauloBergerot) 's Twitter Profile Photo

Fantastic The ASCO Post post of outstanding RCT
- 357 met pts
- 6 countries
- 9mo exercise program:
🏋️resistance
🏃‍♀️aerobic
🤸balance
2x/w

RESULTS:
⬇️fatigue
⬆️QoL
⬇️pain.
💪Encouraged 30 mins/day PA
Michail ignatiadis
Anouk Hiensch

👉ascopost.com/news/march-202…

Fantastic @ASCOPost post of outstanding RCT - 357 met #BreastCancer pts - 6 countries - 9mo exercise program: 🏋️resistance 🏃‍♀️aerobic 🤸balance 2x/w RESULTS: ⬇️fatigue ⬆️QoL ⬇️pain. 💪Encouraged 30 mins/day PA @MIgnatiadis @AnoukHiensch 👉ascopost.com/news/march-202…
account_circle
Ottavia Amato(@Ottavia) 's Twitter Profile Photo

🧪🩸🧬 Liquid biopsy is being progressively integrated in the management of metastatic breast cancer patients. Read our paper at rdcu.be/dA0PK for an overview of available evidence and future perspectives.
Michail ignatiadis npj Journals

🧪🩸🧬 Liquid biopsy is being progressively integrated in the management of metastatic breast cancer patients. Read our paper at rdcu.be/dA0PK for an overview of available evidence and future perspectives. #mbc #bcsm #liquidbiopsy #ctdna @MIgnatiadis @Nature_NPJ
account_circle
Europa Donna(@EuropaDonnaEUR) 's Twitter Profile Photo

It’s the last day of !

Today’s ED Session at EBCC14 covered the important topic of the right to work after a BC diagnosis. Chaired by Elizabeth Bergsten-Nordstrom and Marzia Zambon.
Speakers: Martina Fontana, Darja Molan and Rosanna D'Antona.

OncoAlert European Breast Cancer Conference (EBCC-14)

It’s the last day of #EBCC14! Today’s ED Session at EBCC14 covered the important topic of the right to work after a BC diagnosis. Chaired by Elizabeth Bergsten-Nordstrom and @MarziaZambon. Speakers: Martina Fontana, Darja Molan and Rosanna D'Antona. @OncoAlert @BreastEuropean
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

A HUGE THANK YOU TO ‼️
& our partners at European Breast Cancer Conference (EBCC-14) EORTC , the faculty and staff, our ambassadors🚨 and most importantly all of our colleagues worldwide🌐

✅1⃣2⃣.6⃣Million impressions
✅Almost 1⃣.8⃣K Posts

Making it the European Meeting with the

A HUGE THANK YOU TO #EBCC14 ‼️ & our partners at @BreastEuropean @EORTC , the faculty and staff, our ambassadors🚨 and most importantly all of our colleagues worldwide🌐 ✅1⃣2⃣.6⃣Million impressions ✅Almost 1⃣.8⃣K Posts Making it the European #BreastCancer Meeting with the
account_circle